L. De Clerck

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population (2008)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, DE CLERCK, L, PERETZ, A, VERBRUGGEN, L, ...

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population (2008)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, VAN DEN BOSCH, FILIP, Mielants, Herman, DE CLERCK, L, ...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

Geusens, P, Malaise, M, De Clerck, L, Raeman, F, ...

OBJECTIVE: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. METHODS: In this 24-week, prospective, randomised,...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

Luyten, F. P., GEUSENS, Piet, Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., ...

Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised,...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

Luyten, F. P., GEUSENS, Piet, Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., ...

Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised,...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

LUYTEN, FP, GEUSENS, P, MALAISE, M, DE CLERCK, L, WESTHOVENS, R, RAEMAN, F, ...

Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition (2006)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, Mielants, Herman, DE CLERCK, L, ...

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity (2006)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, ...

Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005)

Boonen, A, Verbruggen, L, Durez, P, De Clerck, L, Malaise, M, ...

The aim of this study was to compare the socioeconomic consequences of early and late rheumatoid arthritis in Belgium and to assess the patient out-of-pocket contributions. This multicentre...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Corluy, L, Veys, E M, De Clerck, L, Peretz, A, ...

OBJECTIVES: To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. METHODS: Patients...

Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, VEYS, EM, ...

Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005)

WESTHOVENS, R, BOONEN, A, VERBRUGGEN, L, DUREZ, P, DE CLERCK, L, MALAISE, M, ...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., De Clerck, L., Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

Timing of DAS28 in infliximab therapy: reply (2005)

Durez, P., Corluy, L., Veys, E., De Clerck, L., Peretz, A., ...

Timing of DAS28 in infliximab therapy: reply (2005)

Durez, P., Corluy, L., Veys, E., De Clerck, L., Peretz, A., ...

Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease (2004)

Van Hul, E, Van Driessche, K, Fransen, E, Devogelaer, J-P, Vanhoenacker, F, ...

A positional cloning effort in French Canadian families with Paget's disease of bone (PDB) resulted in the identification of a mutation in the sequestosome1 (SQSTM1) gene in a subset of both familial...

Ileocolonoscopy and spondarthritis (1988)

Grillet, B, De Clerck, L

Ileocolonoscopy and Spondarthritis (1988)

DEQUEKER, J., GRILLET, B., DE CLERCK, L., RUTGEERTS, P., GEBOES, K.

Systematic ileocolonoscopy and bowel biopsy study in spondylarthropathy (1987)

De Clerck, L

In order to evaluate the frequency of ileitis in a population of patients with spondylarthropathy, an ileocolonoscopy with biopsies was performed in 88 consecutive patients with back pain and/or...

SYSTEMATIC ILEOCOLONOSCOPY AND BOWEL BIOPSY STUDY IN SPONDYLARTHROPATHY (1987)

GRILLET, B., DE CLERCK, L., DEQUEKER, J., RUTGEERTS, P., GEBOES, K.

In order to evaluate the frequency of ileitis in a population of patients with spondylarthropathy, an ileocolonoscopy with biopsies was performed in 88 consecutive patients with back pain and/or...